Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vissum, Instituto Oftalmológico de Alicante, is a world-renowned center of excellence in ophthalmology located in Spain. Founded by Professor Jorge Alió, the institute provides comprehensive eye care services, ranging from routine examinations to complex surgical procedures for cataracts, glaucoma, and retinal diseases. It is particularly distinguished for its leadership in refractive surgery and corneal regeneration research, frequently participating in international clinical trials and technological development. In 2019, Vissum was acquired by Miranza, a leading Spanish group in ocular health, which is part of the European veonet network. The institute continues to operate as a flagship facility, combining high-level clinical practice with an active R&D department focused on advancing ophthalmic science.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vissum Instituto Oftalmológico de Alicante.